WESTLAKE, Ohio--(BUSINESS WIRE)--Nordson Corporation (Nasdaq: NDSN) (the “Company” or “Nordson”) has completed the acquisition of Atrion Corporation (“Atrion”), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. The completion of the transaction follows the Company’s May 28, 2024 announcement that it had entered into an agreement to acquire the business.

俄亥俄州西湖市——（商业新闻短讯）——Nordson Corporation（纳斯达克代码：NDSN）（“公司”或“Nordson”）已完成对Atrion Corporation（“Atrion”）的收购，Atrion Corporation是专有医疗输液输送和利基心血管解决方案的领导者。交易完成之前，该公司于2024年5月28日宣布，已签署收购该业务的协议。

This acquisition will expand Nordson’s medical portfolio into new markets and therapies, supported by long-term secular growth trends..

此次收购将在长期长期增长趋势的支持下，将诺德森的医疗投资组合扩展到新市场和疗法。

The Company will provide comments about the acquisition in its previously announced third quarter fiscal year 2024 webcast, which is scheduled for:

该公司将在之前宣布的2024财年第三季度网络广播中对此次收购发表评论，该网络广播定于：

Date: Thursday, August 22, 2024

日期：2024年8月22日，星期四

Time: 8:30 AM ET

时间：美国东部时间上午8:30

Link to listen: https://events.q4inc.com/attendee/410848164

链接以收听：https://events.q4inc.com/attendee/410848164

Investors who are interested in listening to the webcast, but are not able to participate during the scheduled time, can access the replay by visiting Nordson’s investor website.

有兴趣收听网络广播但无法在预定时间内参与的投资者可以通过访问Nordson的投资者网站访问重播。

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serves global customers through a wide variety of critical applications.

。该公司的直销模式和应用专业知识通过各种关键应用程序为全球客户提供服务。

Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, www.twitter.com/Nordson_Corp or www.facebook.com/nordson..

。该公司成立于1954年，总部位于俄亥俄州的西湖，在35多个国家设有运营和支持办事处。访问Nordson网站：www.Nordson.com、www.twitter.com/Nordson\u Corp或www.facebook.com/Nordson。

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology.

本新闻稿中的某些声明是1995年《私人证券诉讼改革法案》所指的前瞻性声明。前瞻性陈述可以通过术语来识别，例如“可能”、“将”、“应该”、“可能”、“预期”、“预期”、“相信”、“项目”、“预测”、“展望”、“指导”、“继续”、“目标”或这些术语的负面或类似术语。

These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions, including the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S.

这些报表反映了管理层当前的期望，并涉及许多风险和不确定性。这些风险和不确定性包括但不限于美国和国际经济状况；财务和市场状况；货币汇率和贬值；可能的收购，包括公司成功整合收购的能力；公司成功剥离或处置被认为不符合其战略计划的业务的能力；美国变化的影响。

trade policy and trade agreements; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflict between Russia and Ukraine, acts of terror, natural disasters and pandemics, including the recent coronavirus (COVID-19) pandemic and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully.

贸易政策和贸易协定；税法变更的影响；以及我们无法控制的事件的可能影响，例如政治动荡，包括俄罗斯和乌克兰之间的冲突，恐怖行为，自然灾害和大流行，包括最近的冠状病毒（COVID-19）大流行，以及公司最近提交的10-K表年度报告和提交给证券交易委员会的10-Q表中第1A项（风险因素）讨论的其他因素，应仔细审查。

The Company undertakes no obligation to update or revise any forward-looking statement in this press release..

公司没有义务更新或修订本新闻稿中的任何前瞻性声明。